15
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

Dose‐dependent disposition of ethylene glycol in the rat after intravenous administration

Pages 397-409 | Received 26 Jan 1982, Accepted 16 Mar 1982, Published online: 19 Oct 2009
 

Abstract

A dose‐dependent change was observed in the disposition of 14 C‐labeled ethylene glycol (EG) after iv administration of 20, 200, 1000, and 2000 mg/kg to Fischer 344 rats. The part of the dose expired as CO 2 decreased from 39% at 20 and 200 mg/kg to 26% at 1000 and 2000 mg/kg, while urinary excretion of radiocarbon increased from 35 to 56%. The increase in urinary 14 C was almost entirely attributable to [ 14 C] glycolate, which comprised 20% of the dose in 24 h at the two higher dose levels and only 2% at the lower doses. High doses of EG limited the processes responsible for glycolate metabolism, supporting the idea that this acid is a major contributing factor to the acute toxicity of EG. Compensatory urinary excretion of glycolate resulted in minimal dose‐dependent effects on 14 C blood clearance. Blood clearance of 14 C occurred in an initial rapid phase (half‐life, 3–5 h), when plasma was comprised predominantly of ethylene glycol, that persisted for 12 h at 20 mg/kg EG and 30 h at 2000 mg/kg. The dose‐dependent profile of EG metabolism argues against the use of very high chronic doses in studies intended to estimate health risks of long‐term, low‐level exposure to EG.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.